1. Antineoplastics

   Case report 21 October 2023 Pages: 51 - 51

2. Antineoplastics

   Case report 21 October 2023 Pages: 52 - 52

3. Antineoplastics

   Case report 21 October 2023 Pages: 53 - 53

4. Antineoplastics

   Case report 21 October 2023 Pages: 54 - 54

5. Antineoplastics

   Case report 21 October 2023 Pages: 55 - 55

6. Antineoplastics

   Case report 21 October 2023 Pages: 56 - 56

7. Antineoplastics/norethisterone

   Case report 21 October 2023 Pages: 57 - 57

8. Antipsoriatics

   Case report 21 October 2023 Pages: 58 - 58

9. Antithrombotics

   Case report 21 October 2023 Pages: 59 - 59

10. Antithymocyte-globulin/methylprednisolone/tacrolimus

    Case report 21 October 2023 Pages: 60 - 60

11. Apixaban/rivaroxaban

    Case report 21 October 2023 Pages: 61 - 61

12. Aripiprazole

    Case report 21 October 2023 Pages: 62 - 62

13. Arsenic-trioxide/tretinoin

    Case report 21 October 2023 Pages: 63 - 63

14. Aspirin

    Case report 21 October 2023 Pages: 64 - 64

15. Aspirin

    Case report 21 October 2023 Pages: 65 - 65

16. Aspirin

    Case report 21 October 2023 Pages: 66 - 66

17. Aspirin

    Case report 21 October 2023 Pages: 67 - 67

18. Aspirin

    Case report 21 October 2023 Pages: 68 - 68

19. Aspirin/ticagrelor

    Case report 21 October 2023 Pages: 69 - 69

20. Aspirin/ticagrelor

    Case report 21 October 2023 Pages: 70 - 70

21. Atezolizumab

    Case report 21 October 2023 Pages: 71 - 71

22. Atezolizumab

    Case report 21 October 2023 Pages: 72 - 72

23. Atezolizumab/bevacizumab/antineoplastics

    Case report 21 October 2023 Pages: 73 - 73

24. Atorvastatin

    Case report 21 October 2023 Pages: 74 - 74

25. Atropine/carvedilol/diltiazem

    Case report 21 October 2023 Pages: 75 - 75

26. Axicabtagene-ciloleucel/brexucabtagene-autoleucel/tisagenlecleucel

    Case report 21 October 2023 Pages: 76 - 76

27. Azacitidine

    Case report 21 October 2023 Pages: 77 - 77

28. Azacitidine/venetoclax

    Case report 21 October 2023 Pages: 78 - 78

29. Azacitidine/venetoclax

    Case report 21 October 2023 Pages: 79 - 79

30. Azathioprine

    Case report 21 October 2023 Pages: 80 - 80

31. Azathioprine

    Case report 21 October 2023 Pages: 81 - 81

32. Azathioprine/cyclophosphamide

    Case report 21 October 2023 Pages: 82 - 82

33. Azathioprine/dapsone/prednisolone

    Case report 21 October 2023 Pages: 83 - 83

34. Azathioprine/prednisone/vedolizumab

    Case report 21 October 2023 Pages: 84 - 84

35. AZD-1222/SARS-COV-2-vaccine-inactivated-Sinovac-Biotech/Tozinameran

    Case report 21 October 2023 Pages: 85 - 85

36. Baricitinib

    Case report 21 October 2023 Pages: 86 - 86

37. Baricitinib

    Case report 21 October 2023 Pages: 87 - 87

38. Baricitinib/dexamethasone/remdesivir

    Case report 21 October 2023 Pages: 88 - 88

39. Benzylpenicillin/clindamycin

    Case report 21 October 2023 Pages: 89 - 89

40. Benzylpenicillin/doxycycline

    Case report 21 October 2023 Pages: 90 - 90

41. Betamethasone

    Case report 21 October 2023 Pages: 91 - 91

42. Bevacizumab

    Case report 21 October 2023 Pages: 92 - 92

43. Bevacizumab/disitamab-vedotin

    Case report 21 October 2023 Pages: 93 - 93

44. Bevacizumab/paclitaxel

    Case report 21 October 2023 Pages: 94 - 94

45. Bicarbonate/calcium gluconate/insulin

    Case report 21 October 2023 Pages: 95 - 95

46. Bicarbonate/ceftriaxone/immune-globulin

    Case report 21 October 2023 Pages: 96 - 96

47. Bictegravir/emtricitabine/tenofovir-alafenamide

    Case report 21 October 2023 Pages: 97 - 97

48. Bivalirudin/heparin

    Case report 21 October 2023 Pages: 98 - 98

49. Bleomycin

    Case report 21 October 2023 Pages: 99 - 99

50. Bleomycin/cisplatin/etoposide

    Case report 21 October 2023 Pages: 100 - 100